Overview (21 Sep 2026)
Vivo Bio Tech Ltd
VIVOBIOT
INE380K01017

Biotechnology
0.05

Prev. Close
Previous Close
16.71
Current Close
16.76
Current High
17.23
Current Low
16.5
52 Week High
40.5
52 Week Low
16.1
Resistance 1
17.16
Resistance 2
17.56
Support 1
16.43
Support 2
15.70
Std Deviation
12.35%
DMA 200
25.47
DMA 50
20.34
DMA 20
18.07
Fundamentals and Ratios
Standalone
Trailing EPS
-0.93
Forwad EPS
-2.67
Trailing P/E
NA
Forward P/E
NA
PEG Ratio
2.20
Mkt. Cap (Cr)
Market Cap (Cr)
37.19
Total Debt(Cr)
Tot. Debt(Cr)
NA
Reserve (Cr)
NA
Book Value
NA
P/BV Ratio
NA
ROCE(%)
N/A
ROE
N/A
Consolidated
Trailing EPS
4.76
Forwad EPS
2.33
Trailing P/E
3.52
Forward P/E
7.18
PEG Ratio
16.76
Mkt. Cap (Cr)
Market Cap (Cr)
37.19
Total Debt(Cr)
Tot. Debt(Cr)
0.00
Reserve (Cr)
Book Value
994.57
P/BV Ratio
0.16
ROCE(%)
N/A
ROE
N/A

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue14.1413.7713.3713.0212.4252.57
Other Income0.060.030.140.130.140.44
Total Income14.2013.8013.5113.1512.5653.01
Interest1.241.481.401.471.505.85
Expenditure-13.86-13.22-11.93-11.64-11.00-47.82
PBDT0.000.000.000.000.000.00
Depreciation-3.53-2.75-2.66-2.57-2.64-10.63
PBT0.34-0.021.581.511.524.58
Tax-0.15-5.41-0.32-0.64-0.10-6.52
Equity0.000.000.000.000.000.00
OPM2.37-0.1711.8211.6012.219.00
Net Profit0.18-5.441.260.871.37-1.94
NPM1.3-39.499.416.6811.06-4
EPS0.08-2.650.570.450-0.93
Consolidated
TypeDec-25Sep-25Jun-25Mar-25Dec-24FY24-25
Revenue13.5113.1112.5112.2912.2146.67
Other Income0.140.130.140.150.014.81
Total Income13.6513.2412.6512.4412.2251.48
Interest1.401.471.501.681.847.50
Expenditure-12.08-11.73-11.10-11.20-10.76-42.60
PBDT0.000.000.000.000.000.00
Depreciation-2.66-2.57-2.64-2.25-2.25-9.02
PBT1.571.511.481.241.468.79
Tax-0.32-0.64-0.10-0.10-0.64-1.50
Equity0.000.000.000.000.000.00
OPM11.5011.3911.709.9711.9617.08
Net Profit1.250.871.341.060.827.28
NPM9.146.5610.578.546.7114.15
EPS0.560.450.740.690.554.76
Annual Reports

Corporate Action
Quarterly Result
Dividend
Bonus
Split

Mutual Fund Holddings